The present invention is directed towards novel azaindole compounds which bind to the AMP site and are potent FBPase inhibitors. The present invention also is directed towards the clinical use of the novel FBPase inhibitors as a method of treatment or prevention of diseases responsive to lowered blood glucose levels.

 
Web www.patentalert.com

< (none)

< Formulation for electrically assisted delivery of lidocaine and epinephrine

> Process for producing water-soluble polysaccharide

> (none)
~ 00016